BCT Wound dressing officially entering the United Kingdom market

04, Feb 2015

BCT Hydrophilic Wound dressing and Occlusive Wound Dressing successfully enters the United Kingdom National Health Service (NHS) system, officially entering the United Kingdom market.

NHS, United Kingdom publicly funded health care system, is a very important aspect of the social benefits in the United Kingdom. Legal residents and tax payers in the United Kingdom are able to access NHS service for free. The main principle behind NHS is to provide free medical services regardless of income. Over half of the residents in the United Kingdom consider NHS to be the most important government achievement in the 20th century.

BCT Hydrophilic Wound Dressing and Occlusive Wound Dressing uses patented activated Carbon Fiber to adsorb bacteria and wound odor, and releases FIR emission, to stimulate collagen fiber growth, allowing the wound to quickly heal without leaving scars, it is a revolutionary advanced wound dressing.  BCT wound dressing have received USA FDA and China CFDA, certificates from around the world, and most recently the Taiwan Excellence Award.




About Bio-medical Carbon Technology
Bio-medical Carbon Technology, BCT, develops and manufactures ionic silver coated activated carbon fiber wound care dressings. Its products with proven effectiveness backed by the laboratory tests and clinical trials can treat a broad range of wound types, both acute and chronic wounds. It is proven that its products provide an easy, gentle, faster wound healing. BCT operates worldwide and is supported by its professionals and ongoing development and research. For more information, please visit www.bm-carbon.com